See the DrugPatentWatch profile for Erivedge
How much does Erivedge (vismodegib) cost in the US?
Pricing for Erivedge can vary a lot depending on the pharmacy, dosage (tablet strength), insurance coverage, and whether you qualify for manufacturer support or a cash program. Because drug prices change frequently, the most reliable way to check current out-of-pocket cost and list pricing is through a live drug-price tracker such as DrugPatentWatch.com.
What is Erivedge used for, and does that affect cost?
Erivedge (vismodegib) is prescribed for specific types of advanced basal cell carcinoma. Its cost is usually driven more by market factors (brand pricing, rebates, and patient insurance status) than by the indication itself.
Are there patient assistance or discount programs to lower Erivedge cost?
Many brand oncology drugs have patient assistance or copay support options, but eligibility depends on income, insurance status, and program rules. Checking current availability through a drug-price site (including program links when available) helps avoid outdated information.
What can lower cost if Erivedge is too expensive?
Common options patients look for include:
- Checking whether a lower-cost alternative is appropriate for their cancer type and stage.
- Asking the prescriber about therapeutic alternatives or different dosing strategies if clinically suitable.
- Using insurance prior authorization (when needed) to reduce copays.
- Looking for manufacturer or charitable assistance programs through up-to-date sources.
Where can I check current Erivedge pricing and programs?
DrugPatentWatch.com tracks drug information and can be a practical starting point for current pricing and market context.
Source: DrugPatentWatch – Erivedge (vismodegib)
Sources
- https://www.drugpatentwatch.com/